The Indian equity markets, after a euphoric post-COVID bull run that stretched till September 2024, have now entered a phase of correction.

The equity market has turned sharply volatile, with the benchmark Sensex frequently witnessing four-digit swings with alarming ease.

Investors are growing restless as their portfolios stay in the red. Many had pinned their hopes on strong

A company's return on equity (ROE) is influenced by multiple factors, and DuPont Analysis helps us break it down into its key drivers.

All sectors echoed this volatile trajectory, but the pharmaceutical sector stood out.